Invent Medic Sweden AB (XSAT:IMS) Research & Development: kr0.15 Mil (TTM As of Mar. 2026)


XSAT:IMS Invent Medic Sweden AB XSAT:IMS
38 GF Score
Price kr0.13
GF Value kr0.18
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Invent Medic Sweden AB Research & Development?

Invent Medic Sweden AB XSAT:IMS -3.73% 38 Research & Development is kr0.15 Mil as of Mar. 2026. GuruFocus rates XSAT:IMS with a GF Score™ of 38/100 and a GF Value™ of kr0.18 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Invent Medic Sweden AB's Research & Development for the three months ended in Mar. 2026 was kr0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was kr0.15 Mil.

Invent Medic Sweden AB  (XSAT:IMS) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Invent Medic Sweden AB Research & Development Related Terms

Invent Medic Sweden AB Research & Development Historical Data

* Premium members only.

The historical data trend for Invent Medic Sweden AB's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Invent Medic Sweden AB Research & Development Chart

Invent Medic Sweden AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.09 0.37 0.74 0.73 0.34

Invent Medic Sweden AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.19 0.15 0.00 0.00 0.00
XSAT:IMS
38GF Score
Invent Medic Sweden AB XSAT:IMS
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Invent Medic Sweden AB Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.15 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of kr0.15 Mil mean?
Invent Medic Sweden AB (XSAT:IMS) has a Research & Development of kr0.15 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Invent Medic Sweden AB and its competitors.
Is Invent Medic Sweden AB's Research & Development too high?
Invent Medic Sweden AB's current Research & Development is kr0.15 Mil. Overall, Invent Medic Sweden AB has a GF Score™ of 38/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Invent Medic Sweden AB's Research & Development compare to ABT and SYK?
Invent Medic Sweden AB's Research & Development of kr0.15 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Invent Medic Sweden AB and its competitors. Invent Medic Sweden AB's current Research & Development is kr0.15 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Invent Medic Sweden AB stock overvalued right now?
Based on GuruFocus' analysis, Invent Medic Sweden AB (XSAT:IMS) is currently considered Modestly Undervalued. The stock's GF Value™ is kr0.18, compared to a current price of kr0.13 — trading 28.3% below its estimated fair value. The current Research & Development is kr0.15 Mil. Invent Medic Sweden AB's overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Invent Medic Sweden AB (XSAT:IMS), the current Research & Development is kr0.15 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Invent Medic Sweden AB (XSAT:IMS) Overvalued in 2026?

Based on GuruFocus' analysis, Invent Medic Sweden AB stock appears to be undervalued. The current stock price of kr0.13 is trading 28.3% below its estimated GF Value™ of kr0.18. GuruFocus considers Invent Medic Sweden AB to be Modestly Undervalued.

Key valuation signals for XSAT:IMS:

  • Research & Development: kr0.15 Mil
  • GF Value™: kr0.18 vs. price of kr0.13 (28.3% below fair value)
  • GF Score™: 38/100 with 2 warning signs

No single metric tells the full story. See the XSAT:IMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Invent Medic Sweden AB Business Description

Address Nytenkargatan 4, Lund, SWE, 223 63
Invent Medic Sweden AB develops and markets its product - Efemia bladder support, a vaginal medical device for the treatment of female urinary incontinence.
38GF Score

Get the complete analysis for XSAT:IMS

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.13
Price
kr0.18
GF Value